Detalles de la búsqueda
1.
Siltuximab as a primary treatment for cytokine release syndrome in a patient receiving a bispecific antibody in a clinical trial setting.
J Oncol Pharm Pract
; 29(4): 1006-1010, 2023 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-36464766
2.
Health-related quality of life in patients with relapsed or refractory multiple myeloma: treatment with daratumumab, lenalidomide, and dexamethasone in the phase 3 POLLUX trial.
Br J Haematol
; 194(1): 132-139, 2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-33822368
3.
Health-related quality of life maintained over time in patients with relapsed or refractory multiple myeloma treated with daratumumab in combination with bortezomib and dexamethasone: results from the phase III CASTOR trial.
Br J Haematol
; 193(3): 561-569, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33555030
4.
Protocole of a controlled before-after evaluation of a national health information technology-based program to improve healthcare coordination and access to information.
BMC Health Serv Res
; 17(1): 297, 2017 04 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-28431579
5.
Phase II trial of clofarabine with topotecan, vinorelbine, and thiotepa in pediatric patients with relapsed or refractory acute leukemia.
Pediatr Blood Cancer
; 61(3): 431-5, 2014 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-24115731
6.
High-dose cyclophosphamide for the treatment of refractory T-cell acute lymphoblastic leukemia in children.
J Pediatr Hematol Oncol
; 36(5): e265-70, 2014 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-24327129
7.
GPRC5D as a novel target for the treatment of multiple myeloma: a narrative review.
Blood Cancer J
; 14(1): 24, 2024 02 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-38307865
8.
Comparative Efficacy of Talquetamab vs. Current Treatments in the LocoMMotion and MoMMent Studies in Patients with Triple-Class-Exposed Relapsed/Refractory Multiple Myeloma.
Adv Ther
; 41(4): 1576-1593, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38402374
9.
Successful treatment of refractory metastatic histiocytic sarcoma with alemtuzumab.
Cancer
; 118(15): 3719-24, 2012 Aug 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-22170006
10.
How well do diagnosis-related groups explain variations in costs or length of stay among patients and across hospitals? Methods for analysing routine patient data.
Health Econ
; 21 Suppl 2: 6-18, 2012 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-22815108
11.
Diagnosis related groups and variations in resource use for child delivery across 10 European countries.
Health Econ
; 21 Suppl 2: 55-65, 2012 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-22815112
12.
How well do diagnosis-related groups for appendectomy explain variations in resource use? An analysis of patient-level data from 10 European countries.
Health Econ
; 21 Suppl 2: 30-40, 2012 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-22815110
13.
Does integrated care mean fewer hospitalizations? An evaluation of a French field experiment.
Health Policy
; 126(8): 786-794, 2022 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35662533
14.
Economic vulnerability and unmet healthcare needs among the population aged 50 + years during the COVID-19 pandemic in Europe.
Eur J Ageing
; 19(4): 811-825, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34512226
15.
An evaluation of five regional health information technology-based programmes to improve health and social care coordination: A quasi-experimental controlled before/after mixed design.
J Health Serv Res Policy
; 27(2): 122-132, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35156397
16.
Childhood Cancer in Rhode Island.
R I Med J (2013)
; 102(1): 46-49, 2019 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30709075
17.
Correction: GPRC5D as a novel target for the treatment of multiple myeloma: a narrative review.
Blood Cancer J
; 14(1): 40, 2024 Mar 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-38448422
18.
Cost of illness: an international comparison. Australia, Canada, France, Germany and The Netherlands.
Health Policy
; 88(1): 49-61, 2008 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-18407369
19.
Flower visitor insects display an interspecific dominance hierarchy on flowers.
Ecology
; 104(3): e3958, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36520066
20.
Relapsed and refractory pediatric acute myeloid leukemia: current and emerging treatments.
Paediatr Drugs
; 16(2): 151-68, 2014 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-24158739